U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

[X]  Quarterly  report under Section 13 or 15(d) under the  Securities  Exchange
     Act of 1934.

         For the quarterly period ended      September 30, 2001
                                        ------------------------

[ ] Transition report under Section 13 or 15(d) of the Exchange Act.

         For the transition period from           to
                                        ---------    ----------

                        Commission file number 000-28301
                                               ---------

                           ID TECHNOLOGIES CORPORATION
                         ------------------------------
        (Exact Name of Small Business Issuer as Specified in Its Charter)


         North Carolina                                          56-1866233
------------------------------------                         -----------------
   (State or Other Jurisdiction of                           (I.R.S. Employer
   Incorporation or Organization)                           Identification No.)

                        920 Main Campus Drive / Suite 400
                          Raleigh, North Carolina 27606
                     --------------------------------------
                    (Address of Principal Executive Offices)

                                 (919) 424-3722
                 -----------------------------------------------
                (Issuer's Telephone Number, Including Area Code)

                                       N/A

                         -------------------------------
                        (Former Name, Former Address and
                Former Fiscal Year, if Changed Since Last Report)

     Check  whether  the issuer:  (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days.

Yes      X         No
   ---------------   ---------------

     State the number of shares  outstanding of each of the issuer's  classes of
common  equity,  as of the latest  practicable  date:  The issuer had 10,178,450
shares of common stock outstanding as of November 12, 2001.

         Transitional Small Business Disclosure Format (check one):

Yes                No      X
   ---------------   ---------------

<PAGE>

                                FORM 10-QSB INDEX

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

PART I        FINANCIAL INFORMATION
              Item 1.      Financial Statements.
              Item 2.      Management's Plan of Operation.

PART II       OTHER INFORMATION
              Item 1.      Legal Proceedings.
              Item 2.      Changes in Securities and Use of Proceeds.
              Item 3.      Defaults Upon Senior Securities.
              Item 4.      Submission of Matters to a Vote of Security Holders.
              Item 5.      Other Information.
              Item 6.      Exhibits and Reports on Form 8-K.

SIGNATURES

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

     This  Form  10-QSB  contains  forward-looking  statements.  Any  statements
contained in this Form 10-QSB that are not  statements  of  historical  fact are
intended to be and are hereby  identified as  forward-looking  statements within
the  meaning  of the  Private  Securities  Litigation  Reform  Act of  1995.  ID
Technologies  Corporation,  a  North  Carolina  corporation  (the  "Company"  or
"IDTEK")  cautions  readers that forward  looking  statements  involve known and
unknown risks and uncertainties  which could cause actual results or outcomes to
differ  materially  from  those  expressed  in the  forward-looking  statements.
Forward-looking  statements  include  statements  concerning plans,  objectives,
goals,  strategies,  expectations,  future events or performance  and underlying
assumptions and other  statements  which are other than statements of historical
facts.

     Without  limiting the  foregoing,  words such as "may,"  "will,"  "expect,"
"believe,"  "anticipate,"  "estimate,"  "continue" or comparable terminology are
intended to  identify  forward-looking  statements.  These  statements  by their
nature  involve  substantial  risks and  uncertainties,  and actual  results may
differ  materially  depending  on a variety  of  factors,  many of which are not
within the Company's  control.  These factors  include,  but are not limited to,
economic  conditions  generally  and in the  industries in which the Company may
participate;   competition  within  the  Company's  chosen  industry,  including
competition from much larger competitors; technological advances; and failure by
the  Company  to  successfully   develop  potential   products  and/or  business
relationships and strategic alliances.  In addition to other factors and matters
discussed  elsewhere  herein,  the following are important  factors that, in the
view of the Company,  could cause actual results to differ materially from those
discussed in the  forward-looking  statements:  ability of the Company to obtain
acceptable forms and amounts of financing to fund current and future operations,
research and development and acquisitions;  competition; the Company's operating
losses; the Company's ability to commercially develop its proposed products; the
Company's  ability  to  attract,   hire  and  retain  employees  and  management
personnel; and the Company's ability to control the development and exploitation
of its  technology.  The Company  disclaims  any intent or  obligation to update
these forward-looking statements, whether as a result of new information, future
events or otherwise.

<PAGE>

                          PART I FINANCIAL INFORMATION

Item 1.  Financial Statements

<TABLE>
<CAPTION>

ID Technologies Corporation
(A Development Stage Company)
Condensed Balance Sheet

                                                  September 30, 2001    December 31, 2000
                                                         (Unaudited)            (Audited)
                                                         -----------          -----------
<S>                                                     <C>                    <C>
Assets

Current assets:
   Cash and cash equivalents                             $   128,922           $   49,311
   Prepaid expenses                                      $     2,032           $    7,010
                                                         -----------          -----------
       Total current assets                              $   130,954           $   56,321
   Equipment, net                                        $       915           $    1,252
   Patents, net                                          $    26,532           $   19,653
                                                         -----------          -----------
        Total assets                                     $   158,401           $   77,226
                                                         ===========           ==========

Liabilities and shareholders' deficit Current liabilities:

    Accounts payable and accrued liabilities             $    65,212           $   84,053
    Notes payable to shareholder                         $     3,022           $   22,840
    Notes payable, current                               $    71,384           $   60,618
    Short term convertible debt, net of discount
         of $12,242                                      $  176,412            $        0

                                                         -----------          -----------
          Total current liabilities                      $   316,030           $  167,511
   Long term notes payable                               $    26,753           $   35,374
   Long term convertible debt, net of discount
         of $0 and $19,550, respectively                 $         0           $  165,450
   Deferred revenue                                      $   370,108           $  179,218
Shareholders' deficit:
   Common stock                                          $   282,953           $  282,953
   Additional paid in capital                            $ 4,410,032           $4,236,417
   Deficit accumulated during

                development stage                        $(5,247,475)        $(4,989,697)
                                                         -----------          -----------
       Total shareholders' deficit                       $  (554,490)          $ 470,327)
                                                         -----------          -----------
Total liabilities and shareholders' deficit              $   158,401           $   77,226
                                                         ===========           ==========

</TABLE>
<PAGE>
<TABLE>
<CAPTION>


ID Technologies Corporation
(A Development Stage Company)
Condensed  Statement of Operations for the nine months ended  September 30, 2001
and 2000 and for the period from  inception  (March 16, 1994) through  September 30, 2001

                                      9 months ended  9 months ended  Inception 3/16/94
                                      Sept. 30, 2001   Sept.30, 2000   through 9/30/01
                                        (Unaudited)     (Unaudited)      (Unaudited)
                                       ------------     ----------       -----------
<S>                                    <C>             <C>              <C>
License revenue                        $    34,110      $      -         $   128,954
Royalty revenue                        $     4,000      $      -         $     4,000
                                       ------------     ----------       -----------
        Total revenues                 $    38,110      $      -         $   132,954
Research & development                 $       -        $   40,270       $   736,268
Selling, general and
      administrative expenses          $   337,317      $  354,079       $ 4,230,836
                                       ------------     ----------       -----------
         Loss from operations          $  (299,207)     $ (394,349)      $(4,834,150)
Other income and expense:
  Interest income - contractual        $     1,439      $       95       $     4,658
  Gain on disposal of asset            $       -        $      -         $       353
  Forgiveness of debt                  $    20,757      $      -         $    49,474
  Standstill                           $    50,000      $      -         $    50,000
  Amortization of debt discount on     $   (10,962)     $ (187,162)      $  (294,483)
        convertible debentures
  Interest expense                     $   (19,805)     $  (38,826)      $   (97,327)
  Debt conversion expense              $       -        $      -         $  (126,000)
                                       ------------     ----------       -----------
Net loss                               $  (257,778)     $ (620,242)      $(5,247,475)

Basic and diluted loss
   per common share                    $     (0.03)     $    (0.07)

Weighted average number                  9,983,028        8,374,139
      of common shares

<CAPTION>

                                      3 months ended  3 months ended
                                      Sept 30, 2001   Sept 30, 2000
                                        (Unaudited)     (Unaudited)
                                       ------------     ----------
<S>                                    <C>             <C>
License revenue                        $     2,832      $      -
                                       ------------     ----------
        Total revenues                 $     2,832      $      -

Research and Development               $         0      $   30,270
Selling, general and
      administrative expenses          $    90,390      $  127,163
                                       ------------     ----------
         Loss from operations          $  ( 87,558)     $ (157,433)
Other income and expense:
  Interest income - contractual        $       192      $       95
  Standstill                           $    50,000      $      -
  Forgiveness of debt                  $        -       $      -
  Amortization of debt discount on     $    (3,654)     $ (65,854)
        convertible debentures
  Interest expense                     $    (5,500)     $ (15,245)
                                         ------------     ----------
Net loss                               $   (46,520)     $ (238,437)

Basic and diluted loss
   per common share                    $     (0.01)     $    (0.03)

Weighted average number                  10,090,223        8,450,679
      of common shares



</TABLE>
<PAGE>
<TABLE>
<CAPTION>


                                                ID Technologies Corporation
                                               (A Development Stage Company)

                                        Statements of Shareholders' Equity (Deficit)

                              Period from inception (March 16, 1994) through September 30, 2001

                                                                                                  DEFICIT
                                                                                  ADDITIONAL     ACCUMULATED
                                                                                   PAID-IN         DURING
                                                      SHARES         AMOUNT        CAPITAL       DEVELOPMENT      TOTAL
                                                    ----------     ----------     ----------     ----------      ------
<S>                                              <C>              <C>            <C>            <C>              <C>
Balance at March 16, 1994                                 --             --             --             --           --
Issuance of common shares for cash and
   noncash consideration                             1,595,200            366             33           --           399

Net loss                                                  --             --             --             (123)      (123)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 1994                         1,595,200            366             33           (123)        276
Issuance of common shares for cash and
   noncash consideration                               404,800           --              101           --           101

Net loss                                                  --             --             --           (2,263)    (2,263)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 1995                         2,000,000            366            134         (2,386)    (1,886)
Issuance of common shares for cash and
   noncash consideration                             6,000,000           --            1,500           --         1,500

Net loss                                                  --             --             --          (29,889)   (29,889)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 1996                         8,000,000            366          1,634        (32,275)   (30,275)
Issuance of common shares for cash net of
   issuance costs                                      153,333        282,587           --             --       282,587
Capital contribution in form of research
   and development services                               --             --          201,405           --       201,405
Stock-based compensation                                  --             --        1,333,600           --     1,333,600
Net loss                                                  --             --             --       (1,684,313)(1,684,313)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 1997                         8,153,333        282,953      1,536,639     (1,716,588)    103,004
Issuance of common shares for noncash
   consideration                                        22,500           --           45,000           --        45,000
Capital contribution in form of research
   and development services                               --             --          192,319           --       192,319
Stock-based compensation                                  --             --          933,425           --       933,425
Net loss                                                  --             --             --       (1,426,725)(1,426,725)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 1998                         8,175,833        282,953      2,707,383     (3,143,313)  (152,977)
Issuance of warrants in connection with
   issuance of convertible debt                           --             --          271,870           --       271,870
Capital contribution in form of research
   and development services                               --             --          269,441           --       269,441
Issuance of common shares for noncash
   consideration                                       101,750           --          142,165           --       142,165
Net loss                                                  --             --             --         (939,741)  (939,741)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 1999                         8,277,583        282,953      3,390,859     (4,083,054)  (409,242)

Conversion of convertible debt to equity               250,000           --          100,000           --       100,000
Issuance of beneficial conversion features in
   connection with issuance of convertible debt           --             --           31,200           --        31,200
Debt conversion expense                                   --             --          126,000           --       126,000
Capital contribution in form of research and
   development services                                   --             --           72,600           --        72,600
Issuance of common shares for noncash
   consideration                                       211,759           --          116,148           --       116,148
Issuance of common shares for cash                     944,963           --          399,610           --       399,610
Net loss                                                  --             --             --         (906,644)  (906,644)
                                                    ----------     ----------     ----------     ----------      ------
Balance at December 31, 2000                         9,684,305        282,953      4,236,417     (4,989,697)  (470,327)

Issuance of common shares for noncash
   consideration                                        65,499           --           32,497           --        32,497
Issuance of common shares for cash                     257,556           --          103,023           --       103,023
Net loss                                                  --             --             --         (121,054)  (121,054)
                                                    ----------     ----------     ----------     ----------      ------
Balance at March 31, 2001                           10,007,360        282,953      4,371,937     (5,110,751)  (455,861)

Issuance of common shares for noncash
   consideration                                        71,090           --           23,688           --        23,688
Net loss                                                  --             --             --          (90,203)   (90,203)
                                                    ----------     ----------     ----------     ----------      ------
Balance at June 30, 2001                           10,078,450        282,953      4,395,625     (5,200,954)   (522,376)


Issuance of common shares for noncash
   consideration                              55,408           --         14,406        --     14,406
Net loss                                        --             --             --    (46,520)  (46,520)
                                           ----------     ---------    ---------  --------   --------
Balance at Sept 30, 2001                   10,133,858      282,953     4,410,031  (5,247,475)(554,490)


</TABLE>

<PAGE>
<TABLE>
<CAPTION>



ID Technologies Corporation
(A Development Stage Company)
Condensed Statement of Cash Flows
for the nine  months  ended  September 30,  2001 and 2000 and for the period from
inception (March 16, 1994) through Sept 30, 2001

                                                        9 months ending     9 months ending      Inception 3/16/94
                                                        Sept  30,  2001      Sept 30, 2000       through 9/30/01
                                                         --------------       --------------      -------------
                                                           (Unaudited)         (Unaudited)        (Unaudited)
<S>                                                       <C>                 <C>                 <C>
Cash flows from operating activities:
Net loss                                                  $  (257,778)        $  (620,242)        $(5,245,163)
Adjustments to reconcile net loss to net cash
  used in operation activities:
    Depreciation                                          $       338         $       564         $     2,405
    Amortization                                          $     1,221         $     2,988         $    15,771
        Gain on disposal of equipment                     $      --           $      --           $      (353)
    Stock based compensation                              $      --           $      --           $ 2,267,025
    Non-cash marketing expenses                           $      --           $      --           $    49,165
    Non-cash research and development expenses            $      --           $    10,000         $   737,394
    Non-cash professional fees                            $    63,991         $    76,050         $   305,627
    Non-cash interest payments                            $     6,600         $      --           $    13,530
    Debt forgiveness                                      $   (20,757)        $      --           $   (49,474)
    Non-cash debt conversion expense                      $      --           $      --           $   126,000
    Discount on convertible debentures                    $    10,962         $   181,962         $   294,481
    Change in operating assets and liabilities:
          Prepaid expenses                                $     4,978         $    (8,130)        $    (1,840)
          Accounts payable and accrued liabilities        $     1,918         $      (905)        $    91,970
          Deferred revenue                                $   190,890         $    89,062         $   370,108
                                                          -----------         -----------         -----------

Net cash used in operating activities                     $     2,363         $  (268,651)        $(1,023,546)

Cash flows from investing activities:

   Patent costs                                           $    (8,100)        $      --           $   (42,303)
   Purchase of equipment                                  $      --           $      --           $    (3,980)
   Disposal of equipment                                  $      --           $      --           $     1,014
                                                           -----------         -----------         -----------
Net cash used in investing activities                     $    (8,100)        $      --           $   (45,269)

Cash flow from financing activities:

    Proceeds from issuance of notes payable               $    10,000         $      --           $   443,750
    Payment of notes payable                              $   (27,674)        $    49,217         $  (242,591)
    Proceeds from issuance of convertible debt            $      --           $      --           $   665,000
    Payment on convertible debt                           $      --           $      --           $  (380,000)
    Proceeds from sale of common shares                   $   103,022         $   489,770         $   428,620
    Proceeds from issuance of common shares, net          $      --           $      --           $   282,958
                                                          -----------         -----------         -----------
Net cash provided by financing activities                 $    85,348         $   538,987         $ 1,197,737
Increase in cash and cash equivalents                     $    79,611         $   270,336         $   128,922

Cash and cash equivalents, beginning of period            $    49,311         $    62,986         $      --
Cash and cash equivalents, end of period                  $   128,922         $   333,323         $   128,922

</TABLE>


<PAGE>

ID Technologies Corporation
(A Development Stage Company)
Notes to Financial Statements
September 30, 2001
(Unaudited)

1.  Management's Opinion

The accompanying unaudited financial statements have been prepared in accordance
with accounting  principles  generally accepted in the United States for interim
financial  information and with the instructions to Form 10-Q of regulation S-X.
Accordingly they do not include all of the information and footnotes required by
generally accepted accounting principles for complete financial  statements.  In
the  opinion  of  management,  all  adjustments  (consisting  solely  of  normal
recurring  accruals)  considered  necessary  for  a  fair  presentation  of  the
statements have been included. The interim operating results are not necessarily
indicative  of the results  that may be expected  for a full  fiscal  year.  The
balance  sheet at December 31, 2000 has been derived from the audited  financial
statements  at that  date  but  does  not  include  all of the  information  and
footnotes  required by accounting  principles  generally  accepted in the United
States for complete financial statements. For further information,  refer to the
financial  statements  and  accompanying   footnotes  thereto  included  in  the
Company's Annual Report on Form 10-KSB for the year ended December 31, 2000.

2. Licenses

Global Biometrics,  Inc. owned options to purchase four exclusive licenses.  The
options expired unexercised on June 30, 2001.

3. Revenue

License revenue is the  amortization of the Bob Barker Company license valued at
$89,062 and the Global  Biometrics  Inc.  licenses  transferred  from Protek for
$75,000.  The license  fees are being  amortized at rates of $1,895 and $937 per
quarter respectively.

4. Accounts Payable

Payables for  professional  services  totaling $27,757 were settled in full with
payments  totaling  $7,000 with no additional  consideration.  The difference of
$20,757 was recorded as cancellation of debt.

5. Convertible Debt

The annual interest payments on private convertible debentures were paid in full
on June  30,  2001  with  $3,600  paid in cash and  $6,600  paid in stock at the
election  of the debt  holder.  Those  paid in stock were  granted  stock at the
average ask price during the month of June 2001. The holders of $100,000 private
debentures  elected  to defer the  annual  interest  payment  of  $12,000  until
December 15, 2001. The debt holder will be paid the $12,000 plus 12% interest on
the  $12,000  and may  elect a stock  payout  in lieu of cash  for the  original
$12,000 interest payment. The stock price would be the average ask price for the
month of June 2001.

6.  Litigation

The Company filed a lawsuit  against  Fingerprint  Cards AB ("FPC") on April 19,
2001 in the United  States  District  Court for the  Eastern  District  of North
Carolina seeking, inter alia, a declaratory judgment regarding  non-infringement
and  unenforceability  of the  Lofberg  patent.  The  complaint  was  amended in
September 2001 by IDTEK to also include business  interference by FPC, demanding
treble  damages  as a result of faxing  the to an IDTEK  licensee  of a document
alleging  infringement  by IDTEK.  The  Company  is the  owner of US Patent  No.
5,623,552  which  is  presently  a  principal  patent  in  biometric  technology
applications  involving a  stand-alone,  integrated  card for  fingerprint-based
identification and access.

Item 2.  Management's Plan of Operation.

The Company is engaged in the development of biometric  technologies,  know-how,
and products for licensing  worldwide.  The Company holds the patent for a card,
panel,   or   substrate   allowing   "on-board"   storage   and   authentication
(identification) of fingerprints with a frontier biometric market size estimated
to be multibillion  dollars.  The potential  applications of this technology are
many  and  varied:  from  welfare  cards  to  loyalty/medical   records/personal
information cards to controlling the use of firearms.

The development and production of this biometric breakthrough was managed by the
Company's  scientific  partner,  SafeNet of  Baltimore,  Maryland.  SafeNet is a
leading  provider of network and  Internet  security  systems and  technologies.
SafeNet is a holder of approximately 12% of the Company's common stock and holds
a Company  license in the fields of  Internet,  computer  network,  banking  and
treasury  fields  worldwide  which SafeNet  sublicensed  in perpetuity to Global
Biometrics in the fourth quarter of 2000.

A prototype 8 chip card was completed in April 2001, as well as a  comprehensive
manufacturing plan by SafeNet, to build a single-chip  production card at a cost
below $20 in future years.

The  non-recurring  engineering  cost (NRE) to reduce the technology to a single
chip will be the  responsibility of engineering  supply firms,  including Global
Biometrics and other engineering firms. These development costs are estimated at
approximately $1,700,000.

Global Biometrics  purchased the engineering  development rights from SafeNet in
November 2000 for  $1,400,000.  IDTEK or its suppliers have the right to develop
biometric  fingerprint cards.  Currently,  IDTEK has no plans to develop its own
biometric fingerprint card.

Presently,  the  Company  has initial  licenses  in place with  SafeNet,  Global
Biometrics,  Power^Up, Bob Barker Company and BrentScott,  which are expected to
yield  $400,000  in  additional   license  fees  when  card  production  begins.
Production  is currently  expected to begin in 2002.  The licenses to Bob Barker
Company,  SafeNet and Global  Biometrics  are paid in full.  The options  Global
Biometrics  had for four  additional  licenses  expired  unexercised on June 30,
2001.  The  Company  will  attempt to sell those  licenses  to other  interested
parties, but makes no assurances that it will be able to do so.

On August 6,  2001,  the  Company  entered  into a  teaming  agreement  with GRC
International  ("GRCI"), an AT&T subsidiary,  to provide leading-edge biometrics
technologies  development,  systems  integration,  and  fielding.  GRCI  will be
responsible  for  bidding  and system  integration  of  products  deploying  the
Company's technology.

The Company believes it has to be the first-to-market  leader with the following
competitive advantages:

-        A biometric  fingerprint  card with storage and a power source (lithium
         battery) on board.

-        A  biometric  fingerprint  card which will not  require an  independent
         power source.

-        A  biometric   fingerprint  card   safeguarding   personal  privacy  (a
         government or corporate database system is unnecessary).

-        A biometric fingerprint card with 113 mps of computing power (the power
         of a Palm Pilot).

The Company's biometric  fingerprint card is essentially a stand-alone  computer
on a card protected by the Lane Foundation  patent:  United States Patent Number
5,623,552  issued on April 22, 1997 with an  enforceable  life until  August 15,
2015. Another biometric patent was filed in February 2001.

The Company has been a development stage company with nominal revenues since its
inception. Losses were $1,684,313 in 1997, $1,426,725 in 1998, $939,741 in 1999,
$906,644 in 2000 and $257,778 in the first nine months of 2001.

<PAGE>

As of September  30, 2001,  the Company had  approximately  $129,000 in cash and
cash  equivalents.  Currently,  the  Company has a cash burn rate of $20,000 per
month.

With  the  Company's   current  policy  of  contracting   out   development  and
concentrating on licensing of intellectual  property and marketing,  the Company
does not plan to  purchase  any  equipment  or buy or rent  plant(s) in the next
year, other than possibly computers.

     Results of Operations

     The following  discussion  provides an analysis of the Company's results of
operations  and  liquidity  and  capital  resources.  This  should  be  read  in
conjunction with the financial  statements of the Company and notes thereto. The
operating results of the periods  presented were not  significantly  affected by
inflation.

     Comparison of Nine Months Ended September 30, 2001 and 2000:

     License  revenue  for the first nine months of 2001 was $34,110 as compared
to zero for the same  period of 2000.  The  license  revenue is  comprised  of a
$25,000  license  transfer  fee from SafeNet to  sublicense  in  perpetuity  the
license to Global  Biometrics and $9,110 of  amortization  of the Bob Barker and
Global  Biometrics'  licenses.  No new license  agreements  were sold during the
third quarter.  Royalty revenue for the nine months ended September 30, 2001 was
$4,000 as  compared to zero for the same  period of 2000.  The royalty  payments
recorded during the period are for SafeNet sales to a British  government agency
that uses the Company's technology.  Royalty payments are predicated on the sale
price of the cards to end-users by licensees.

     The research and development  expenses are a non-cash entry in prior years,
which mirrors exactly  SafeNet's  research and development cash expenses for the
development  of the  biometric  fingerprint  card.  SafeNet  did not  incur  any
research  and  development  costs in the nine months  ended  September  30, 2001
compared to $10,000 for the nine months ended  September  30, 2000.  Even though
SafeNet,  the Company's former  development  partner and holder of approximately
12% of the  Company's  capital  stock,  was  responsible  for and incurred  this
expense,  the  Company  records the expense  because  the Company  receives  the
benefits from SafeNet's research.

     The development of the card is now being done by Global  Biometrics,  which
purchased the  development  rights from SafeNet in November 2000 for $1,400,000.
Other card engineering firms are also developing a fingerprint card.

     Selling,  general, and administrative expenses during the nine months ended
September 30, 2001 were  $337,317,  down 4.7% from the $354,079 of such expenses
in the prior  year  period.  The  variance  is  primarily  due to  decreases  in
professional fees and financing expenses.

     Amortization of debt discount on convertible  debentures was $10,962 in the
first nine months of 2001 compared to $187,162 in the first nine months of 2000.
This is a  non-cash  expense  to  amortize  the value of  options  and  warrants
associated with the $485,000 of convertible  debt issued by the Company in 1999.
The Company  paid off $300,000 of the debt in the fourth  quarter of 2000,  thus
the $57,000 per quarter of amortization related to that debt was not recorded in
the first nine months of 2001.

      Interest  expense was $19,805 in the first nine months of 2001,  down from
$38,826  in the first  nine  months of 2000.  The  interest  is 12% on  $185,000
convertible debentures issued in April through June of 1999 and 14% on a $50,000
note payable issued June 2000. In the first nine months of 2000, the Company was
also liable for $300,000 in  convertible  debentures  with an 8% interest  rate.
These debentures were repaid with interest in the fourth quarter of 2000.

     The Company's net  operating  loss for the nine months ended  September 30,
2001 was $299,205,  down 24.1% from the net  operating  loss of $394,349 for the
nine months ended September 30, 2000.

Recent Developments

IDTEK  and  Global  Biometrics  entered  into a 60  day  standstill  for  Global
Biometrics to consider the acquisition of IDTEK. The $50,000  standstill fee was
forfeited to IDTEK when the standstill agreement expired without an agreement on
October 26, 2001.

IDTEK  borrowed  $60,000 at prime plus 2% interest from J. Phillips L. Johnston,
the Chief Executive Officer and William F. Lane, Chairman, which amounts are due
November 26, 2001.

On October 31, 2001,  J.  Phillips L.  Johnston,  the Chief  Executive  Officer,
agreed to accept  the  Company's  stock in lieu of salary.  Expenses  and health
insurance  of $687 per month  continue  to be paid by the  Company.  The average
trade price  during the first month of each  quarter  determines  the  quarterly
payment in stock. The price per share cannot be less than $.26.

                            PART II OTHER INFORMATION

Item 1.  Legal Proceedings.

         The Company  filed a lawsuit  against  Fingerprint  Cards AB ("FPC") on
April 19, 2001 in the United States  District Court for the Eastern  District of
North  Carolina   seeking,   inter  alia,  a  declaratory   judgment   regarding
non-infringement  and  unenforceability of the Lofberg patent. The complaint was
amended in September 2001 by IDTEK to also include business interference by FPC,
demanding  treble  damages as a result of faxing the to an IDTEK  licensee  of a
document alleging infringement by IDTEK.

         The  Company  is not  involved  in any  other  material  pending  legal
proceeding adverse to the Company.

Item 2.       Changes in Securities and Use of Proceeds.

         The  Company  issued  160,569  shares of common  stock in  payment  for
$63,991 of  professional  services at various market prices  averaging $0.40 per
share. The Company also issued 31,428 common shares to private debenture holders
in lieu of $6,600 in interest payments due in June 2001.

         The Company relied on the securities registration exemption provided by
Section 4(2) of the Securities Act of 1933, as amended, in connection with these
stock  issuances  since  these  were  privately  negotiated   transactions  with
individuals who each had an existing business relationship with the Company.

Item 3.       Defaults Upon Senior Securities.

     None.

Item 4.  Submission of Matters to a Vote of Security Holders.

     No matters  were  submitted to a vote of security  holders  during the nine
months ended September 30, 2001.

Item 5.       Other Information.

     None.


Item 6.       Exhibits and Reports on Form 8-K.

(A) EXHIBITS.

Exhibit
   No.                    Description
--------                  -----------
    3                     Articles   of   Incorporation,   together   with   all
                          amendments  thereto,  filed  as  Exhibit  2.01  to the
                          Registrant's Form 10-SB filed as of November 30, 1999,
                          filed with the SEC,  which is  incorporated  herein by
                          reference to such Form 10-SB.

   3.1                    Bylaws, filed as Exhibit 2.02 to the Registrant's Form
                          10-SB filed as of November  30,  1999,  filed with the
                          SEC, which is incorporated herein by reference to such
                          Form 10-SB.

    4                     Form of Debenture  Purchase Agreement by and among the
                          Company   and   purchasers   of  the   Company's   12%
                          Convertible Subordinated Debentures due 2002, filed as
                          Exhibit 3.01 to the  Registrant's  Form 10-SB filed as
                          of November  30,  1999,  filed with the SEC,  which is
                          incorporated herein by reference to such Form 10-SB.

   4.1                    Form of 12%  Convertible  Subordinated  Debenture  Due
                          2002, filed as Exhibit 3.02 to the  Registrant's  Form
                          10-SB filed as of November  30,  1999,  filed with the
                          SEC, which is incorporated herein by reference to such
                          Form 10-SB.

   4.2                    Registration  Rights Agreement,  dated as of December
                          31, 1997,  between  the Company and  Hutchison & Mason
                          PLLC, filed as  Exhibit 3.04 to the Registrant's  Form
                          10-SB filed as of November 30,  1999,  filed with the
                          SEC,  which is  incorporated  herein  by  reference to
                          such Form 10-SB.

   4.3                    Stock Purchase Agreement,  dated as of August 1, 1997,
                          by and among the  Company,  Li-Pei Wu and  William  F.
                          Lane (as agent for  certain  sellers),  together  with
                          Addendum  to Stock  Purchase  Agreement  of even  date
                          therewith,  filed as Exhibit 3.04 to the  Registrant's
                          Form 10-SB filed as of November 30,  1999,  filed with
                          the SEC, which is incorporated  herein by reference to
                          such Form 10-SB.

   4.4                    Convertible Debenture,  dated September 24, 1999, made
                          by  the  Company  in  favor  of   Centennial   Venture
                          Partners,   LLC,   filed  as   Exhibit   3.05  to  the
                          Registrant's Form 10-SB filed as of November 30, 1999,
                          filed with the SEC,  which is  incorporated  herein by
                          reference to such Form 10-SB ("CVP").

   4.5                    Common Stock Purchase  Warrant,  dated,  September 24,
                          1999,  made by the  Company  in favor of CVP  (450,000
                          shares),  filed as  Exhibit  3.06 to the  Registrant's
                          Form 10-SB filed as of November 30,  1999,  filed with
                          the SEC, which is incorporated  herein by reference to
                          such Form 10-SB.

   4.6                    Common Stock  Purchase  Warrant,  dated  September 24,
                          1999,  made by the  Company  in favor of CVP  (150,000
                          shares),  filed as  Exhibit  3.07 to the  Registrant's
                          Form 10-SB filed as of November 30,  1999,  filed with
                          the SEC, which is incorporated  herein by reference to
                          such Form 10-SB.

   4.7                    Common Stock  Purchase  Warrant,  dated  September 24,
                          1999,  made by the  Company  in favor of CVP  (200,000
                          shares),  filed as  Exhibit  3.08 to the  Registrant's
                          Form 10-SB filed as of November 30,  1999,  filed with
                          the SEC, which is incorporated  herein by reference to
                          such Form 10-SB.

   4.8                    Common Stock  Purchase  Warrant,  dated  September 24,
                          1999,  made  by the  Company  in  favor  of CVP (up to
                          $500,000),  filed as Exhibit 3.09 to the  Registrant's
                          Form 10-SE filed as of November 30,  1999,  filed with
                          the SEC, which is incorporated  herein by reference to
                          such Form 10-SB.

   4.9                    Investor Rights  Agreement,  dated as of September 24,
                          1999, by and among the Company and certain  holders of
                          its  capital  stock,  filed  as  Exhibit  3.10  to the
                          Registrant's Form 10-SB filed as of November 30, 1999,
                          filed with the SEC,  which is  incorporated  herein by
                          reference to such Form 10-SB.

  4.10                    Shareholders  Agreement,  dated September 24, 1999, by
                          and among the  Company and  certain  shareholders  and
                          investors,  filed as Exhibit 3.11 to the  Registrant's
                          Form 10-SB filed as of November 30,  1999,  filed with
                          the SEC, which is incorporated  herein by reference to
                          such Form 10-SB.

  4.11                    Form of Warrant to Purchase  Common  Stock  issued  by
                          the Company to various investors in 2000.

   10                     License Agreement,  dated October 1, 1999, between the
                          Company  and  BrentScott  Associates,  LLC,  filed  as
                          Exhibit 6.01 to the  Registrant's  Form 10-SB filed as
                          of November  30,  1999,  filed with the SEC,  which is
                          incorporated herein by reference to such Form 10-SB.

  10.1                    Patent License Agreement, dated July 30, 1997, between
                          the  Company  and  Information  Resource  Engineering,
                          Inc., filed as Exhibit 6.02 to the  Registrant's  Form
                          10-SB filed as of November  30,  1999,  filed with the
                          SEC, which is incorporated herein by reference to such
                          Form 10-SB.

  10.2                    License Agreement, dated October 31, 1999, between the
                          Company  and  Revolution  Labs,  Inc.  ("Revolution"),
                          together  with  the   agreement   among  the  Company,
                          Revolution   and   Protective    Technologies,    Inc.
                          ("Protek")  regarding the potential purchase by Protek
                          of  Revolution's  fields of license,  filed as Exhibit
                          6.03  to  the  Registrant's  Form  10-SB  filed  as of
                          November  30,  1999,  filed  with  the  SEC,  which is
                          incorporated herein by reference to such Form 10-SB.

  10.3                    Agreement,  dated  March 30,  1999,  among  Safe Guard
                          Corporation, Protek, Secure  Card International, Inc.,
                          International  Biometrics  Incorporated,   Tele-Guard,
                          Inc.  and  the  Company,  filed as Exhibit 6.04 to the
                          Registrant's  Form  10-SE  filed  as of  November  30,
                          1999,  filed  with  the SEC,  which  is  incorporated
                          herein by reference to such Form 10-SB.

  10.4                    License  Agreement  dated February 2, 1999 between the
                          Company and Power^Up Marketing  Corporation,  filed as
                          Exhibit 6.05 to the  Registrant's  Form,10-SB filed as
                          of November  30,  1999,  filed with the SEC,  which is
                          incorporated herein by reference to such Form 10-SB.

  10.5                    Debenture  Purchase  Agreement,  dated  September  24,
                          1999,  between the  Company  and  certain  purchasers,
                          filed as Exhibit 6.06 to the  Registrant's  Form 10-SB
                          filed as of  November  30,  1999,  filed with the SEC,
                          which is incorporated herein by reference to such Form
                          10-SB.

  10.6                    1999 Stock Option  Plan,  filed as Exhibit 6.07 to the
                          Registrant's Form 10-SB filed as of November 30, 1999,
                          filed with the SEC,  which is  incorporated  herein by
                          reference to such Form 10-SB.

  10.7                    Form of  Incentive  Stock Option  Agreement,  filed as
                          Exhibit 6.08 to the  Registrant's  Form 10-SB filed as
                          of November  30,  1999,  filed with the SEC,  which is
                          incorporated herein by reference to such Form 10-SB.

  10.8                    Employment   Agreement   between   the    Company  and
                          CEO/President   Mr. J.  Phillips  L.  Johnston,  dated
                          November  9,  1999  filed   as  Exhibit  10.8  to  the
                          Registrant's  Form 10-KSB  for the year ended December
                          31, 1999 which is incorporated  herein by reference to
                          such Form 10-KSB.

  10.9                    License Agreement  with Bob Barker Company, Inc. filed
                          as Exhibit 10  to the Registrant's Form 10-QSB for the
                          quarter   ended   September    30,   2000,   which  is
                          incorporated herein by reference to such Form 10-QSB.

  10.10                   License  Agreement  between the Company and Protective
                          Technology,   Inc.  dated  October 24, 2000  filed  as
                          Exhibit 10.10 to the Registrant's Form 10K-SB for  the
                          fiscal year ending December  31, 2000  filed  with the
                          SEC, which is incorporated by  reference to  such Form
                          10K-SB.

  10.11                   Amended and Restated License Agreement dated  February
                          2001 between the Company and  Protective Technologies,
                          Inc. filed as Exhibit 10.11  to the Registrant's  Form
                          10K-SB  for the fiscal year ending December  31,  2000
                          filed  with   the   SEC,  which   is  incorporated  by
                          reference to such Form 10K-SB.

  10.12                   Amended   and   Restated   License   Agreement   dated
                          February,  2001  between the  Company  and  Protective
                          Technologies,   Inc.  filed as  Exhibit  10.12  to the
                          Registrant's  Form  10K-SB  for the fiscal year ending
                          December  31,  2000  filed  with  the  SEC,  which  is
                          incorporated by reference to such Form 10K-SB.

  10.13                   Amended   and   Restated   License   Agreement   dated
                          February,  2001  between the  Company  and  Protective
                          Technologies,   Inc.  filed as  Exhibit  10.13  to the
                          Registrant's  Form  10K-SB  for the fiscal year ending
                          December  31,  2000  filed  with  the  SEC,  which  is
                          incorporated by reference to such Form 10K-SB.

  10.14                   Amended   and   Restated   License   Agreement   dated
                          February,  2001  between the  Company  and  Protective
                          Technologies,   Inc.  filed as  Exhibit  10.14  to the
                          Registrant's  Form  10K-SB  for the fiscal year ending
                          December  31,  2000  filed  with  the  SEC,  which  is
                          incorporated by reference to such Form 10K-SB.

  10.15                   Amended   and   Restated   License   Agreement   dated
                          February,  2001  between the  Company  and  Protective
                          Technologies,   Inc.  filed as  Exhibit  10.15  to the
                          Registrant's  Form  10K-SB  for the fiscal year ending
                          December  31,  2000  filed  with  the  SEC,  which  is
                          incorporated by reference to such Form 10K-SB.

  10.16                   Amended   and   Restated   License   Agreement   dated
                          February,  2001  between the  Company  and  Protective
                          Technologies,   Inc.  filed as  Exhibit  10.16  to the
                          Registrant's  Form  10K-SB  for the fiscal year ending
                          December  31,  2000  filed  with  the  SEC,  which  is
                          incorporated by reference to such Form 10K-SB.

  10.17                   Teaming  Agreement  dated  August 1, 2001  between the
                          Company and GRC International, Inc.



(b)      Reports on Form 8-K.

         None.

                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  registrant
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

                                      ID TECHNOLOGIES CORPORATION


                                  BY  /S/ J. Phillips L. Johnston
                                      ------------------------------------------
DATE:    November 14, 2001            J. Phillips L. Johnston, President and CEO


                                      /S/ William F. Lane
                                      ------------------------------------------
DATE:    November 14, 2001             William F. Lane, Chairman and Treasurer
                                      (Principal Financial Officer)